Dr. Martin Madaus, the former CEO of Millipore, is stepping away from Covidien's board to become the CEO of an unnamed company.
Covidien (NYSE:COV) said Dr. Martin Madaus will step down from its board of directors to take an open CEO position with a privately-owned company.
A California federal judge OKs a $2.5 million settlement agreement in a purported class action lawsuit accusing Covidien of urging workers not to take breaks.
A federal judge last week granted preliminary approval to a $2.5 million settlement deal between Covidien (NYSE:COV) and a purported class of workers in California who accused the medical device company of pressuring workers not to take breaks.
Given Imaging's PillCam Colon device lands 510(k) clearance from the FDA.
Given Imaging (NSDQ:GIVN) said it won 510(k) clearance from the FDA for its PillCam Colon, a modified version of its PillCam device.
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Buckle up, because in this video, the PillCam takes viewers for a ride on the GI tract.
The PillCam, made by Israel's Given Imaging (NSDQ:GIVN) was recently acquired by Covidien (NYSE:COV) for $864 million.
Covidien's Japanese branch receives Shonin approval from the Japanese Ministry of Health, Labor & Welfare for the company's Endo GIA Reinforced Reload with Tri-Staple technology.
Covidien (NYSE:COV) said its Japanese branch secured regulatory approval for its Endo GIA surgical staple system.
Covidien CFO Charles Dockendorff plans to retire at the end of 2014, leaving a vacancy in a role he's filled for 25 years.
Covidien (NYSE:COV) said it's searching for a new CFO after Charles Dockendorff announced his plans to retire from the company at the end of 2014.
Dockendorff has been with the company since 1989, serving in a variety of finance-related roles. He was named CFO of Covidien predecessor Tyco Healthcare in 1995, helping lead the company to $10 billion in sales in 2007.